Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
03/2009
03/12/2009WO2009031920A1 Hypoglycemic agent and method for the production thereof
03/11/2009CN101384276A Method for preparing insulin preparation for oral using
03/10/2009US7501498 Moncolonal antibody for use in diagnosis and treatment of cell proliferative disorders; immunotherapy; tissue engineering
03/10/2009US7501394 Bacteriophage T7 clone containing a truncated coat p10 and a wild-type tail fiber protein p17 selectively localizes to hepatocytes when injected into a blood vessel in a mammal; T7 p17 protein and drug, component of a drug or polynucleotide complex and polynucleotide
03/05/2009US20090060837 Cobalamin conjugates useful as antitumor agents
03/04/2009EP2030630A1 Method for removing a prostate tumour and suitable contrasting agent
03/04/2009EP1569630A4 Methods for preventing phototoxic damage during photodynamic therapy
03/04/2009CN101378657A Nucleic acid-degrading agent and method for degradation of nucleic acid
03/03/2009US7498421 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome
03/03/2009US7498029 Photoimmunotherapies for cancer using combination therapies
02/2009
02/26/2009WO2009026430A2 Liposome formulations of boronic acid compounds
02/26/2009WO2009026427A2 Liposome compositions for in vivo administration of boronic acid compounds
02/26/2009WO2009024771A2 Materials and methods for treating cancers which express folate receptors
02/26/2009WO2008014060A3 Microparticle
02/26/2009US20090053247 Biological materials and uses thereof
02/26/2009US20090053186 Therapy for primary and metastatic cancers
02/26/2009CA2697044A1 Liposome formulations of boronic acid compounds
02/26/2009CA2697042A1 Liposome compositions for in vivo administration of boronic acid compounds
02/25/2009EP2026765A2 Hyperthermic technologies and therapeutic uses thereof
02/24/2009US7494503 Method and apparatus for acne prevention
02/24/2009CA2355044C Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport
02/18/2009CN101370522A Specific therapy using integrin ligands for treating cancer
02/12/2009DE202008003806U1 Extrakt für die Herstellung von pharmazeutischen Therapeutika und dessen Verwendung als Nahrungs- oder Lebensmittel oder Nahrungsergänzungsmittel Extract for the manufacture of pharmaceutical therapeutics and its use as a foodstuff or dietary supplement
02/11/2009CN201192460Y Disposable light avoid type photosensitive agent storage releasing piece
02/10/2009CA2255681C Composition and method for treating herpes simplex
02/10/2009CA2223522C Use of 5-aminolevulinic acid for treating or detecting rapidly growing cells of exogenous origin
02/04/2009EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease
02/04/2009EP2019590A1 Methods for treating diseases involving stress-related diseases and conditions
02/03/2009US7486984 System and method for monochromatic x-ray beam therapy
02/03/2009US7485627 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
02/03/2009US7485427 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered
02/03/2009CA2323150C New porphyrins and their use
01/2009
01/29/2009WO2009014101A1 Novel sulfonated sugar derivative, and use thereof for medicinal agent
01/29/2009WO2008076333A9 Polymer-drug conjugates with tether groups for controlled drug delivery
01/29/2009CA2694512A1 Hyperthermia devices and their uses with nanoparticles
01/28/2009EP2018173A1 Magnetorheological fluids and therapeutic uses thereof
01/28/2009CN100455328C Method of treating biological materials with translating electrical fields and electrode polarity reversal
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7481781 Ultrasound therapy
01/27/2009US7481758 Pharmaceutically enhanced low-energy radiosurgery
01/27/2009CA2346644C Method for preventing xenograft transplant rejection using photodynamic therapy
01/22/2009US20090023639 Methods of Treatment
01/22/2009US20090022707 contacting target cells with a therapeutic quantity of a soluble antibody that specifically binds tumor necrosis factor-related apoptosis inducing ligand receptor(TRAIL) DR5, and contacting target cells with a therapeutic agent
01/21/2009EP2016930A2 A cell therapy method for the treatment of tumors
01/21/2009EP0711127B2 Methods of preparing gas-filled liposomes
01/21/2009CN101347623A Multifunctional nanodevice platform
01/20/2009US7479503 Such as multiple sclerosis; also inactivating HIV virus via extracorporeal treatment of blood; use of a green porphyrin or porfimer sodium
01/20/2009CA2423252C Photosensitisers
01/15/2009WO2008116635A3 Composition for the topical/dermic application of homeopathic agents
01/15/2009US20090016965 Internal image antibodies for optical imaging and therapy
01/14/2009EP1509254B1 New agents for magnetic imaging method
01/14/2009EP1199996A4 Real-time monitoring of photodynamic therapy over an extended time
01/14/2009CN101346438A Amphipathic squarylium cyanine dyes, its preparation method and use thereof
01/14/2009CN101346159A Method of activating a photosensitizer
01/13/2009US7476659 Especially a chitosan in which the amine group is substituted with a photocurable carbonylazide, sulfonylazide, aromatic azide, or formyl styryl group and irradiating with light during surgery to form an insoluble hydrogel
01/13/2009US7476383 Antiproliferative agent; induction apoptosis; antitumor agents
01/08/2009US20090011975 Targeted bone marrow protection agents
01/07/2009EP2010146A1 Homeopathic composition and kit therefore
01/07/2009EP1471940B1 Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitisers
01/07/2009EP1223973B1 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization
01/07/2009CN101340930A Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrations in flexible containers using agitation
01/06/2009CA2371818C Salicylamide-lanthanide complexes for use as luminescent markers
01/06/2009CA2144406C Gene transcription and ionizing radiation: methods and compositions
01/02/2009DE112006002974T5 Verfahren zum Aktivieren eines Photosensibilisators A method of activating a photosensitizer
01/01/2009US20090004142 A cell therapy method for the treatment of tumors
12/2008
12/31/2008WO2009001243A1 Apparatus for controlled delivery of molecules using a controlled injection system
12/31/2008WO2009000504A2 Injectable formulation for photodynamic therapy
12/31/2008WO2009000445A1 Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process
12/31/2008WO2008108941A3 Integrated photoactive peptides and uses thereof
12/31/2008WO2008088586A9 New phototherapeutic materials prepared through nanoparticle assembly
12/31/2008WO2008055159B1 Flash photolysis therapy for regulation of physiological function
12/31/2008WO2008055159A4 Flash photolysis therapy for regulation of physiological function
12/31/2008EP2008669A1 Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process
12/31/2008EP2008665A1 Injectable formulation for photodynamic therapy
12/31/2008EP2007418A1 Reversibly inhibited antibodies for immune cell stimulation
12/31/2008EP1424942B1 Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy
12/31/2008CA2688586A1 Irradiation apparatus for inactivating pathogens and/or leukocytes in a biological fluid and process
12/30/2008CA2253207C Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy
12/25/2008US20080319377 Medical Device for Generating Transient Bubbles
12/25/2008US20080319320 Method of imaging lymphatic system using nanocapsule compositions
12/24/2008WO2008156460A1 Bioconjugated nanoparticles
12/24/2008WO2008154927A1 Novel methods for treating egfr-associated tumors
12/23/2008US7468432 Cobalamin conjugates useful as antitumor agents
12/23/2008CA2383248C Apparatus for electrically preparing injectable substances
12/18/2008US20080312325 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
12/18/2008US20080312219 Biologically active methylene blue derivatives
12/18/2008US20080312150 Treatment and analysis of proliferative disorders
12/17/2008EP1306380B1 Novel expanded porphyrins and process for the synthesis thereof
12/17/2008CN101325977A System and method for monitoring in vivo drug release using overhauser-enhanced NMR
12/10/2008EP2000150A2 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
12/09/2008US7462345 Radionuclide labeling of vitamin B12 and coenzymes thereof
12/04/2008WO2008145609A1 Method of making covalent conjugates with his-tagged proteins
12/04/2008WO2008076333A8 Polymer-drug conjugates with tether groups for controlled drug delivery
12/04/2008WO2008035343A3 Artificial receptors
12/03/2008EP1997513A1 Photodynamic therapy for treating conditions of the eye
12/03/2008EP1996508A1 Water-soluble magnetic or metal oxide nanoparticles coated with ligands, preparation method and usage thereof
12/03/2008EP1996148A2 Combined energy and topical composition application for regulating the condition of mammalian skin
12/03/2008CN100438909C 化合物 Compound
12/02/2008US7458982 Photokinetic delivery of biologically active substances using pulsed incoherent light
11/2008
11/27/2008WO2008108944A3 Integrated photoactive small molecules and uses thereof
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 95